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ABSTRACT
Objective: To evaluate and analyze variables related to the surgical and direct post-operative outcomes of our initial 
experience of laparoscopic living donor nephrectomies (LLDN). Material & methods: This retrospective analysis 
describes the first 10 laparoscopic nephrectomies in living donors performed in Cipto Mangunkusumo Hospital. All 
surgeries were performed by the same surgical team. Variables related to the surgical and post-operative outcome and 
complications in donors were evaluated and analyzed. Results: The average age of the donors was 31.8 years with male : 
female ratio of 7 : 3. Thirty percent of them were family related to the recipient. The left kidney was extracted from all 
patients and multiple renal vessels were found in one cases. The mean operation time was 321.9 ± 27 min, first warm 
ischemia time was 9.37 ± 3.34 min and estimated blood loss was 270 ± 182.87ml. The hospital stay was 4.1 ± 1.3 days, VAS 
in the first day post surgery was 3 ± 1 with epidural analgesia needed for 1.8 ± 0.6 days, and drain was kept in for 2.8 ± 1.2 
days while urethral cathether for 2.4 ± 1.2. Time to return to work was 16 ± 8.4 days. Conclusion: LLDNresults in 
acceptable blood loss, less post-operative pain, short hospital stay and short time to return to work for the donors, therefore 
promising to be the gold standard among living donor nephrectomy surgical options.
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ABSTRAK
Tujuan: Mengevaluasi dan menganalisa variabel yang berhubungan dengan pembedahan dan hasil pasca-operasi 
laparoscopic living donor nephrectomies (LLDN). Bahan & cara: Analisa retrospektif ini menjelaskan 10 laparoskopik 
nefrektomi pertama pada donor hidup yang dilakukan di RS Cipto Mangunkusumo Jakarta. Semua pembedahan dilakukan 
oleh tim bedah yang sama. Variabel yang berhubungan dengan pembedahan dan hasil paska-operasi dan komplikasi pada 
donor dievaluasi dan dianalisa. Hasil: Rerata usia pendonor 31.8 tahun, dengan rasio laki-laki : wanita adalah 7 : 3. 
Sebanyak 30% dari pendonor adalah keluarga para pendonor. Ginjal kiri diekstrak dari semua pasien dan multiple renal 
vessels ditemukan ada 1 kasus. Rerata waktu operasi adalah 321.9 ± 27 min, waktu warm ischemia pertama adalah 9.37 ± 
3.34 min dan estimasi kehilangan darah adalah 270 ± 182.87 ml. Waktu tinggal di RS adalah 4.1 ± 1.3 days, VAS pada hari 
pertama pasca operasi adalah 3 ± 1 dengan epidural analgesia dibutuhkan untuk 1.8 ± 0.6 hari, dan drain selama 2.8 ± 1.2 
hari sementara kateter uretra selama 2.4 ± 1.2. Waktu kembali bekerja adalah 16 ± 8.4 hari. Simpulan: LLDN memberikan 
hasil  kehilangan darah yang tidak banyak, luka paska-operasi yang lebih sedikit, waktu tinggal di RS yang pendek, dan 
waktu kembali bekerja yang lebih pendek bagi pendonor, oleh karena itu menjanjikan sebagai gold standard diantara 
pilihan pembedahan nefrektomi donor hidup.
Kata kunci: Nefrektomi donor hidup laparoskopi, transplantasi ginjal, Indonesia.
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INTRODUCTION
Since the first successful kidney transplant 
in 1954, kidney transplant continues to grow until 
today it has become the primary manage-
ment/treatment of choice in patients with end-stage 
1renal disease (ESRD).  However, although kidney 
transplant procedure has been proven to be success-
ful for more than 50 years, there is still a gap between 
the number of patients with end-stage renal disease 
with renal transplants that had been performed. This 
is mainly caused by the imbalance between demand, 
which represents the number of patients with end-
2stage renal disease and the availability of kidneys.
Various attempts have been made to increase 
the availability of kidneys, such as by developing 
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various techniques of kidney transplant surgery. The 
source of kidney availability, in addition from a 
cadaver, is from a living donor. Living donors are 
now regarded as a promising potential to increase the 
3number of available kidneys.  A variety of surgical 
procedures on the donor kidney is being developed 
to provide comfort and little complications after 
surgery on the donor.
Although living donor kidney removal with 
the classical surgery method is a quite safe procedure 
with a mortality rate of 0.03%, the procedure has few 
complications, such as acute or chronic pain due to 
surgical wound, surgical wound infections, the risk 
of incisional hernia, longer hospital stay and delayed 
return to normal activity. The incidence of these 
complications varies with the range of 15-20% or 
4,5more.
In 1995, to reduce complications 
experienced by the donors, for the first time Ratner et 
al. successfully developed kidney removal in living 
donor with laparoscopic method. Various studies 
conducted afterwards showed that laparoscopic 
living donor nephrectomy (LLDN) has various 
advantages over classical surgical procedures, such 
as better cosmetics, lighter pain, shorter duration of 
hospital stay, and the patient returns to normal 
activities more quickly. On the other hand, the 
function of donor kidneys removed with LLDN 
method also does not show different outcome from 
2,3,6,7those removed with classical surgical method.
With a variety of advantages, LLDN now 
become the method of choice to remove the donor 
kidney, which is widely used around the world. In 
2005, 40% of living donor kidney removal in Europe 
was performed with LLDN, while in 2003 in the 
United States living donor kidney removal using 
LLDN reached 67%. With milder postoperative 
pain, shorter hospitalization time, shorter time to 
reactivate life, and various other convenience for 
donors, LLDN is believed to increase the motivation 
3,6and the number of living donors.
In Indonesia kidney transplant procedures 
have been performed since 1977, and up to now more 
than 300 procedures have been performed.8 This 
figure is much less when compared with kidney 
transplantation in the United States. Donor kidney 
removal procedure in Indonesia in general is still 
using classical surgical method. To reduce the risk of 
complications and to improve donor comfort, Cipto 
Mangunkusumo Hospital (RSCM) has started to 
develop donor kidney removal with laparoscopic 
method, which in turn is expected to increase the 
number of living kidney donors.
OBJECTIVE
This study aimed to evaluate and analyze 
variables related to operation and post-operative 
outcome at 10 early experiences in the application of 
LLDN at Cipto Mangunkusumo Hospital, Jakarta, 
Indonesia.
MATERIAL & METHOD
Clinical and operation data were obtained 
from medical records of the first 10 patients who 
underwent  Laparoscopic  L iv ing  Donor  
Nephrectomy (LLDN) the procedure in Cipto 
Mangunkusumo Hospital (RSCM), Jakarta, 
Indonesia. The analyzed variables were age, family 
relationships, warm ischemia time, operation time, 
bleeding during surgery, complications during 
treatment, hospitalization time, and a length of time 
to return to work.
RESULTS
The characteristics of kidney donors who 
underwent LLDN in RSCM were male-dominated 
with the ratio of male : female was 7 : 3, and the 
average age of 31.8 ± 8.4 years (table 1). Average 
weight of the donors was 63.8 ± 8.2 kg with average 
BMI was 23.23 ± 3.33. Only three (30%) of the 
donors had family relationship with the recipient. 
Donated kidney was taken from the left side of the all 
kidney donors.
Table 1. Demographic data. 
Parameters   
Age 31.8 ± 8.4 years (19-47) 
Male : female ratio 7 : 3  
Kinship 30% related (n = 3) 
Nephrectomy side 100% left  
Bodyweight 63.8 ± 8.2 kg  
BMI 23.23 ± 3.33  
Length of operation with LLDN took an 
average time of 321.9 ± 27.0 minutes with a range of 
277-364 minutes. The average warm ischemia time 1 
was 9.37 ± 3.34 minutes, followed by cold ischemia 
with an average of 29.17 ± 15.23 minutes, then warm 
ishemia 2 with an average of 52.26 ± 7.56 minutes. 
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The average time of urine discharge was 6.82 ± 8.39 
minutes. Average intraoperative bleeding was 270 ± 
182.87 mL. Of 10 LLDN procedures performed, 
there was one case complicated with multiple renal 
arteries (table 2).
From table 3, a total of 4 (40%) donors had 
urinary retention complications, whereas infection 
of wound drain occurred in 2 (20%) donors. One case 
needed postoperative transfusion, but there were no 
complications that lead to death. Pain score on the 
first postoperative day had an averaged VAS 3 ± 1. 
Bupivacaine 0.125 mg and 10 mg morphine were 
given epidurally to all donors with an average length 
of 1.8 ± 0.63 days. The use of postoperative drain 
was performed on all donors with an average length 
of 2.8 ± 1.2 days of use and production of 161 ± 
100.49 cc. Urinary catheters were used in all donors 
with an average length of 2.4 ± 1.2 days of use. 
Table 2. Intraoperative data.
Parameters   
Operation time 321.9 ± 27.0 min (277-364) 
Warm ishemia 1 time 9.37 ± 3.34 min (4.88-15.5) 
Cold ischemia time 29.17 ± 15.23 min (14.6-68.4) 
Warm ishemia 2 time 52.26 ± 7.56 min (40.85-63) 
Urine discharge time 6.82 ± 8.39 min (0.91-29.25) 
Intraoperative bleeding 270 ± 182.87 mL (100-600) 
Multiple renal arteries 10 % (n = 1) 
Table 3. Postoperative data.
Parameters   
Donor with one or more post-operative complications 60% (n = 6) 
        Infection on drain site 20% (n = 2) 
        Retention 40% (n = 4) 
        Post-op. blood transfusion 10% (n = 1) 
VAS H+1 3 ± 1 (2-4) 
Epidural analgesia* 1.8 ± 0.63 days (1-3) 
Drain production 161 ±  100.49 cc (10-350) 
Length of drain use 2.8 ± 1.2 days (2-6) 
Length of catheter use 2.4 ± 1.2 days (2-4) 
Length of hospital stay 4.1 ± 1.37 days (3-6) 
Length to regain normal activity at home 9.0 ± 5.91 days (4-21) 
Length to go back to work 15.8 ± 7.94 days (6-30) 
Death due to the operation 0% (n = 0) 
Table 4. Diet and mobilization during hospitalization.
Parameters H+1 H+2 H+3 
Diet 80% soft ; 20% solid 10% soft ; 90% solid     100% solid 
Mobilization 100% sit 30% sit ; 70% walk 10% sit ; 90% walk 
   
*Analgesic used was Bupivacaine 0.125 mg and 10 mg morphine.
Average length of stay in the hospital was 4.1 ± 1.37 
days, and an averagely in 9.0 ± 5.91 days the donors 
were able to return to normal activities at home. The 
length of time to go back to work was averagely 15.8 
± 7.94 days.
During the hospitalization, on the first day 
as many as 80% of the patients received soft diet, 
while on the second day as many as 90% of the 
patients received solid food, and 100% on the third 
day. In terms of mobilization, on the first day post-
surgery, all the donors could sit, on the second day 
70% of the donors could walk, and it increased to 
90% on the third day (table 4).
DISCUSSION
The average age of donors who underwent 
LLDN in this study was 31.8 ± 8.4 years and can be 
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categorized as young adults. Whereas, the average 
BMI was 23.33 ± 3.33, classified as normal. Older 
age donors are still subjected to dispute, because 
there has been reported a physiological decline in 
glomerular filtration and an increased risk of intra-
6and postoperative complications.  However, several 
studies reported that LLDN procedure can be 
performed on donors over the age of 60 years with 
1,9good results.  Now the consensus of the experts 
transplants in the UK recommends that age alone is 
not an absolute contraindication, but donors aged 
over 60 years should undergo a thorough suitability 
6assessment as a donor.
Obesity is not a contraindication for LLDN 
procedure. However, donors with obesity should 
undergo a thorough preoperative evaluation to rule 
out cardiovascular, respiratory, and kidney diseases. 
This is because obesity is associated with an 
1,6increased risk of perioperative complications.
Donated kidneys in this study were taken 
entirely from the left side. Left kidney is generally 
preferred because the renal veins is longer. In 
addition, LLDN is also more difficult for the right 
kidney because the presence of the liver blocks and 
1,4,6complicates the surgical field.  However, research 
conducted by Boorjian et al. (2004) showed that the 
right kidney can also be used in LLDN safely, and 
they found no differences in morbidity and 
remarkable impairment of renal function than that 
10using the left kidney.
The average length of LLDN surgery in this 
study was 321.9 ± 27.0. Four years after introducing 
LLDN for the first time, Ratner published his 
experience. The average length of LLDN surgery 
1,11 performed by Ratner et al. was 230 ± 29 minutes.
This shorter length of operation was due to more 
experience they had. Along with the increase in 
LLDN procedures performed in the RSCM, it is 
expected that the quality and duration of LLDN 
operation in the RSCM becomes better. In contrast to 
the length of operation, the average intraoperative 
bleeding in this study was 270 ± 182.87 ml, not much 
different from that reported by Ratner et al. of 266 ± 
1,11174.
Warm ischemia time in kidney donor with a 
classic open surgery method is shorter than that in 
LLDN. However, research has shown that there are 
no negative effects on kidney function if the warm 
6 ischemia time is under 10 minutes. In this study, the 
average warm ischemia was 9.37 ± 3.34 minutes, and 
it was expected to be better as they gain experience. 
In this study, there was one case complicated by 
multiple renal arteries. Multiple renal arteries can be 
found in 12-33% of cases of laparoscopic living 
donor nephrectomy. Several previous studies found 
that kidneys with multiple renal arteries are 
associated with high rate of vascular and urologic 
complications, such as thrombosis and ischemic 
ureters, so they are sometimes used as a relative 
12contraindication.  However, some recent research 
suggests that kidney transplants with multiple renal 
13-15arteries is safe enough to perform.
In this study, after operation, donors who 
underwent LLDN were given epidural analgesia 
with bupivacaine 0.125 mg added with 10 mg 
morphine on average for 1.8 ± 0.63 days. With these 
interventions, the first day pain post-LLDN 
procedure assessed with VAS revealed an average 
value of 3 ± 1. Drain was placed on the donors for an 
average of 2.8 ± 1.2 days, with an average production 
161 ± 100.49 cc, with a range of 10-350 cc. The 
majority of donors (90%) have been able to eat solid 
foods on the second day post- surgery. Similarly, in 
regard with mobilization, most (70%) of the donors 
had been able to run on the second day post-surgery.
Of 10 donors who underwent LLDN, none 
had conversion to open surgical methods, as well as 
deaths due to surgery. In this study, the majority of 
complications were urinary retention (n = 4), 
followed by surgical wound infection (n = 2) and one 
donor (n = 1) required postoperative transfusion. In 
his research, Ratner argued that transient thigh 
paresthesia is the most common complication 
(4.1%) followed by postoperative transfusion 
11(3.5%) and wound infections (2.9%).  While the 
research conducted by Flowers et al (1997) 
suggested that the most common complications are 
bleeding (6%). Also in the same study they that 
reported urinary retention occurred in 1.4% of 
5patients.
Average length of stay in the hospital was 
4.1 ± 1.37 days, while averagely in 9.0 ± 5.91 days 
the donors have been able to return to normal 
activities at home and averagely in 15.8 ± 7.94 days 
the donor was able to work again. Data presented by 
Ratner in his research showed surprisingly longer 
1time to return to work, which was 28 ± 16.1 days.
Recipients who underwent transplantation 
and received donor kidney had an average age of 
52.1 ± 14.6 years. Average recipient with creatinine 
levels decrease within 48 hours after surgery was 
60.5 ± 20.9%, with 3 recipients (30%) experienced 
delayed graft function (DGF). However, there was 
no recipient who required hemodialysis within the 
first week post-surgery.
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Table 5. Comparison of perioperative parameters with those in other similar studies.
Parameters  This study Ratner et al
11 Flower et al5 
Laparoscopic Laparoscopic Laparoscopic 
Patients (n) 10 323 69 
Duration of operation (min) 321.9 ± 27.0 230 ± 29 226.3 
Intraoperative bleeding (mL) 270 ± 182.87 266 ± 174 122.3 
Warm ischaemia 1 time (min) 9.37 ± 3.34 ND ND 
Cold ischaemia time (min) 29.17 ± 15.23 ND ND 
Warm ischaemia 2 time (min) 52.26 ± 7.56 ND ND 
Length of hospital stay (hr) 4.1 ± 1.37 3.0 ± 0.9 2.2 
Resume working (hr) 15.8 ± 7.94 28 ± 16.1 15.9 
CONCLUSION
LLDN is a fairly safe procedure. LLDN also 
provides other benefits such as less intraoperative 
bleeding, less postoperative pain and lighter 
complications, shorter hospital stay and shorter time 
to return to work. In the end, the numbers of living 
kidney donors expected to increase. With a variety of 
advantages, LLDN procedure has potential to be 
developed to become primary choice in living donor 
kidney nephrectomy surgery.
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